About UsCompany OverviewLeadership TeamEcosystem & ImpactCareers
SciencepLNP TechnologyEnsaliX PlatformPipeline & ApplicationsPublications
PartnershipWhy Partner With UsHow to PartnerPartner JourneyStart a Partnership
Our ProductsEnsaliX Chips
NewsroomNewsPublicationsPress Releases
NanoPalm leadership in the laboratory
Partnership

Co-Develop With NanoPalm

NanoPalm applies its delivery platform to co-develop therapeutics while maintaining an aligned, partner-centric business model.

Driving Value Through a De-Risking Model

NanoPalm's pLNP platform addresses key scientific and commercial challenges of conventional LNPs — helping partners advance novel therapies with greater confidence, speed, and regulatory readiness.

Safety De-Risking

Ionizable lipid-free design reduces a key source of toxicity in conventional LNP systems.

Targeting De-Risking

Ligand-free self-targeting enables delivery to extra-hepatic tissues without active ligands.

Stability De-Risking

Semi-solid patterned architecture improves stability and reduces cold-chain burden.

IP De-Risking

Differentiated IP landscape beyond crowded conventional LNP space, with co-IP pathways.

Regulatory De-Risking

CMC-aligned manufacturing supports reproducibility, scalability, and regulatory readiness.

Co-Development

Every formulation tailored to your payload, target organ, route, and clinical objective.

A Flexible Model for Every Program

From First Conversation to Clinical Readiness

A structured, milestone-driven co-development journey — from early feasibility to IND-enabling readiness.

01
1 month

Initial Discussion

Customized collaboration framework

02
3 months

Feasibility Program — POC

Formulation report & initial data

03
3 months

Optimization

Lead candidate & IP strategy

04
6 months

Preclinical Development

Preclinical data package

05
2 months

IND-Enabling Support

IND-enabling readiness package

What You Receive

pLNP Chips, pLNP formulations, preclinical data, co-IP potential

Our Commitment

Scientific support, milestone tracking, regulatory documentation

The Outcome

Validated delivery system ready for clinical planning

De-Risking Value

Ionizable lipid-free, reduced cold-chain, expanded IP, CMC-ready

Start a Partnership With NanoPalm

Explore how NanoPalm's pLNP platform can accelerate and de-risk your next therapeutic program.

Start a Partnership